Organization: Health Canada
Year: 2021
Month: February
Request Number: A-2020-001210
Request Summary: All records to Health Canada from Novartis or submissions made by Novartis to Health Canada concerning the standards and criteria that should be applied by Health Canada when assessing the bioequivalence and/or bioavailability of octreotide acetate suspension products for approval, when such products rely upon the approval of Novartis’ drug. Time frame would be any time after January 1, 2015.
Disposition: No records exist
Number of pages: 0